148 related articles for article (PubMed ID: 7911394)
1. Reversal of multidrug resistance by RU 486.
Gruol DJ; Zee MC; Trotter J; Bourgeois S
Cancer Res; 1994 Jun; 54(12):3088-91. PubMed ID: 7911394
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
Yang JM; Goldenberg S; Gottesman MM; Hait WN
Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
[TBL] [Abstract][Full Text] [Related]
3. Lack of reversal of daunorubicin resistance in HL60/AR cells by cyclosporin A.
Gollapudi S; Gupta S
Anticancer Res; 1992; 12(6B):2127-32. PubMed ID: 1363515
[TBL] [Abstract][Full Text] [Related]
4. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis.
Bourgeois S; Gruol DJ; Newby RF; Rajah FM
Mol Endocrinol; 1993 Jul; 7(7):840-51. PubMed ID: 8105374
[TBL] [Abstract][Full Text] [Related]
5. Multidrug resistance mediated by P-glycoproteins.
Schinkel AH; Borst P
Semin Cancer Biol; 1991 Aug; 2(4):213-26. PubMed ID: 1680493
[TBL] [Abstract][Full Text] [Related]
6. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent verapamil derivative for monitoring activity of the multidrug transporter.
Lelong IH; Guzikowski AP; Haugland RP; Pastan I; Gottesman MM; Willingham MC
Mol Pharmacol; 1991 Oct; 40(4):490-4. PubMed ID: 1681415
[TBL] [Abstract][Full Text] [Related]
8. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates.
Stein WD; Cardarelli C; Pastan I; Gottesman MM
Mol Pharmacol; 1994 Apr; 45(4):763-72. PubMed ID: 7910372
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
[TBL] [Abstract][Full Text] [Related]
10. Reversal of inherent multidrug-resistance in primary human renal cell carcinoma cell cultures by S 9788.
Efferth T; Dunn TA; Berlion M; Langenbahn H; Pommerenke EW; Volm M
Anticancer Res; 1993; 13(4):905-8. PubMed ID: 8102519
[TBL] [Abstract][Full Text] [Related]
11. Characterization of rhodamine 123 binding to P-glycoprotein in human multidrug-resistant cells.
Nare B; Prichard RK; Georges E
Mol Pharmacol; 1994 Jun; 45(6):1145-52. PubMed ID: 7912815
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the transport function of membrane proteins by some substituted phenothiazines in E. coli and multidrug resistant tumor cells.
Molnár J; Hevér A; Fakla I; Fischer J; Ocsovski I; Aszalós A
Anticancer Res; 1997; 17(1A):481-6. PubMed ID: 9066699
[TBL] [Abstract][Full Text] [Related]
13. Pervilleine A, a novel tropane alkaloid that reverses the multidrug-resistance phenotype.
Mi Q; Cui B; Silva GL; Lantvit D; Lim E; Chai H; You M; Hollingshead MG; Mayo JG; Kinghorn AD; Pezzuto JM
Cancer Res; 2001 May; 61(10):4030-7. PubMed ID: 11358822
[TBL] [Abstract][Full Text] [Related]
14. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.
Piwnica-Worms D; Chiu ML; Budding M; Kronauge JF; Kramer RA; Croop JM
Cancer Res; 1993 Mar; 53(5):977-84. PubMed ID: 8094997
[TBL] [Abstract][Full Text] [Related]
15. Scytophycins, novel microfilament-depolymerizing agents which circumvent P-glycoprotein-mediated multidrug resistance.
Smith CD; Carmeli S; Moore RE; Patterson GM
Cancer Res; 1993 Mar; 53(6):1343-7. PubMed ID: 8095179
[TBL] [Abstract][Full Text] [Related]
16. Resistance to tetracycline, a hydrophilic antibiotic, is mediated by P-glycoprotein in human multidrug-resistant cells.
Kavallaris M; Madafiglio J; Norris MD; Haber M
Biochem Biophys Res Commun; 1993 Jan; 190(1):79-85. PubMed ID: 8093660
[TBL] [Abstract][Full Text] [Related]
17. Drugs transported by P-glycoprotein inhibit a 40 pS outwardly rectifying chloride channel.
Bear CE
Biochem Biophys Res Commun; 1994 Apr; 200(1):513-21. PubMed ID: 7909435
[TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
19. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistant transgenic mice as a novel pharmacologic tool.
Mickisch GH; Pastan I; Gottesman MM
Bioessays; 1991 Aug; 13(8):381-7. PubMed ID: 1683231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]